Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7093)
All Articles published online
|
Publishing Process of This Article
|
Jun 24, 2020 (publication date) through May 23, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Panyavaranant P, Manchana T. Preoperative markers for the prediction of high-risk features in endometrial cancer. World J Clin Oncol 2020; 11(6): 378-388 [PMID: 32874951 DOI: 10.5306/wjco.v11.i6.378] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i6/378.htm |
| Number | Citing Articles |
| 1 |
Kelechi Njoku, Chloe E. Barr, Emma J. Crosbie. Current and Emerging Prognostic Biomarkers in Endometrial Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.890908
|
| 2 |
Chloe E. Barr, Kelechi Njoku, Eleanor R. Jones, Emma J. Crosbie. Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features. Diagnostics 2022; 12(11): 2834 doi: 10.3390/diagnostics12112834
|
| 3 |
Chloe E. Barr, Jamie C. Sergeant, Heather J. Agnew, James Bolton, Rhona J. McVey, Emma J. Crosbie. Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study. BJOG: An International Journal of Obstetrics & Gynaecology 2023; 130(8): 941 doi: 10.1111/1471-0528.17417
|
| 4 |
Roya Behrouzi, Chloe E. Barr, Emma J. Crosbie. HE4 as a Biomarker for Endometrial Cancer. Cancers 2021; 13(19): 4764 doi: 10.3390/cancers13194764
|
| 5 |
K. Shawn LyBarger, Hunter A. Miller, Hermann B. Frieboes. CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-22026-1
|
| 6 |
Sh. T. Ibadova. Structure of Hyperplastic Processes of the Uterus in Menopausal Women According to the Results of an Echographic Study. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2022; 7(4): 36 doi: 10.26693/jmbs07.04.036
|
| 7 |
Yingsha Yao, Liujing Shi, Xiaoming Zhu. Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions. Diagnostics 2023; 13(21): 3301 doi: 10.3390/diagnostics13213301
|
| 8 |
Li‐na Han, Yi‐wei Han, Ping Yan. Prognostic values of human epididymis protein 4 expression in patients with endometrial cancer: A systematic review and meta‐analysis. Journal of Obstetrics and Gynaecology Research 2022; 48(9): 2255 doi: 10.1111/jog.15356
|
| 9 |
Pengfei Guo, Lirui Wu, Huiying Wang, Lanpeng Wang, Hongxia Li, Hongli Wang, Yajuan Wang, Shujuan Shao, Suning Chen. The Relationship between Systemic Expression Levels of Immune Cells and Tumor Markers and High-Risk HPV Infection in Patients with Cervical Cancer, Cervical Intraepithelial Neoplasia, and Chronic Cervicitis, and its Clinical Significance. International Journal of Women's Health 2025; : 1263 doi: 10.2147/IJWH.S515393
|
| 10 |
Pinyada Panyavaranant, Juthamas Rattanachaipipat, Tarinee Manchana. Clinicopathological characteristics and survival outcomes of women aged ≤45 and >45 years with endometrial adenocarcinoma in tertiary referral hospital: a 21-year cohort study. BMJ Open 2025; 15(1): e089434 doi: 10.1136/bmjopen-2024-089434
|
| 11 |
X.N. Yue, X.Y. He, J.J. Wu, W. Fan, H.J. Zhang, C.W. Wang. Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion. Clinical Radiology 2023; 78(8): e574 doi: 10.1016/j.crad.2023.04.005
|
| 12 |
Qiaoyan Lin, Yongwei Lu, Rong Lu, Yujuan Chen, Linghua Wang, Jianping Lu, Xianren Ye. Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study. Therapeutics and Clinical Risk Management 2022; : 789 doi: 10.2147/TCRM.S372371
|
| 13 |
Hunter A. Miller, Anh Tran, K. Shawn LyBarger, Hermann B. Frieboes. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients. European Journal of Surgical Oncology 2024; 50(1): 107309 doi: 10.1016/j.ejso.2023.107309
|
| 14 |
Anna Jagodzińska, Anita Chudecka-Głaz, Kaja Michalczyk, Ewa Pius-Sadowska, Sylwia Wieder-Huszla, Anna Jurczak, Bogusław Machaliński. The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus. Diagnostics 2023; 13(3): 399 doi: 10.3390/diagnostics13030399
|
| 15 |
Caner KOSE, Büşra KÖRPE, Vakkas KORKMAZ, Yaprak USTUN. Preoperatif Belirteçlerin Endometriyal İntraepitelyal Neoplazi Hastalarında Endometriyum Kanserini Öngörmedeki Rolü. Türk Kadın Sağlığı ve Neonatoloji Dergisi 2022; 4(3): 128 doi: 10.46969/EZH.1136385
|
| 16 |
Xiaoning Yue, Xiaoyu He, Shuaijie He, Jingjing Wu, Wei Fan, Haijun Zhang, Chengwei Wang. Multiparametric magnetic resonance imaging-based radiomics nomogram for predicting tumor grade in endometrial cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1081134
|